Heart transplantation is the most effective treatment for end-stage heart failure, advanced cardiomyopathy, and complex congenital heart disease with severe heart failure or hypoxia. Several clinical studies have shown significant differences in the prognosis of heart transplantation patients with different etiologies, and post-transplantation complications are an important factor affecting patient survival, and there is still a lack of overall prognostic stratification and extensive clinical studies on risk factors after heart transplantation. Therefore, this study is intended to include patients who underwent heart transplantation for different etiologies of heart failure, collect clinical data and biological samples from patients, and use various techniques to deeply interpret the risk factors affecting the prognosis of heart transplantation patients and construct a prognostic prediction model to provide specific and individualized treatment ideas and theoretical basis for improving the survival rate of patients after heart transplantation.
Study Type
OBSERVATIONAL
Enrollment
1,000
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
RECRUITINGChange in the incidence of all-cause death
Death from any cause in patients after heart transplantation, will be assessed from medical records.
Time frame: In-hospital (an average of 1 month), 1, 2, 3, 5, 10, 15 and 20 years after heart transplantation.
Use of advanced life support (ALS)
Duration of ALS after heart transplantation, will be assessed from medical records.
Time frame: In-hospital (an average of 1 month)
Incidence of postoperative complications
Postoperative complications after heart transplantation will be assessed from medical records.
Time frame: In-hospital (an average of 1 month)
ICU admission time
ICU admission time after heart transplantation, will be assessed from medical records.
Time frame: In-hospital (an average of 1 month)
Change of cardiac function index
Cardiac functional index after heart transplantation will be assessed by transthoracic echocardiography.
Time frame: In-hospital (an average of 1 month).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.